These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18937118)

  • 1. Self-amplification of nigral degeneration in Parkinson's disease: a hypothesis.
    Ionov ID
    Int J Neurosci; 2008 Dec; 118(12):1763-80. PubMed ID: 18937118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
    Fitzmaurice PS; Ang L; Guttman M; Rajput AH; Furukawa Y; Kish SJ
    Mov Disord; 2003 Sep; 18(9):969-76. PubMed ID: 14502663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional anatomy of noradrenergic neurons in Parkinson's disease.
    Soldani P; Fornai F
    Funct Neurol; 1999; 14(2):97-109. PubMed ID: 10399622
    [No Abstract]   [Full Text] [Related]  

  • 6. Norepinephrine: The redheaded stepchild of Parkinson's disease.
    Rommelfanger KS; Weinshenker D
    Biochem Pharmacol; 2007 Jul; 74(2):177-90. PubMed ID: 17416354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ Is Parkinson's disease due to deficiency of dopamine?].
    Castrén E
    Duodecim; 2005; 121(7):782-3; author reply 783-4. PubMed ID: 15909967
    [No Abstract]   [Full Text] [Related]  

  • 8. Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson's disease.
    Villar-Cheda B; Sousa-Ribeiro D; Rodriguez-Pallares J; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    J Cereb Blood Flow Metab; 2009 Feb; 29(2):230-4. PubMed ID: 18957989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the locus coeruleus in the development of Parkinson's disease.
    Gesi M; Soldani P; Giorgi FS; Santinami A; Bonaccorsi I; Fornai F
    Neurosci Biobehav Rev; 2000 Aug; 24(6):655-68. PubMed ID: 10940440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease: return of an old prime suspect.
    Sulzer D; Schmitz Y
    Neuron; 2007 Jul; 55(1):8-10. PubMed ID: 17610813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper pathology in vulnerable brain regions in Parkinson's disease.
    Davies KM; Bohic S; Carmona A; Ortega R; Cottam V; Hare DJ; Finberg JP; Reyes S; Halliday GM; Mercer JF; Double KL
    Neurobiol Aging; 2014 Apr; 35(4):858-66. PubMed ID: 24176624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blood-brain barrier in health and chronic neurodegenerative disorders.
    Zlokovic BV
    Neuron; 2008 Jan; 57(2):178-201. PubMed ID: 18215617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locus Coeruleus atrophy doesn't relate to fatigue in Parkinson's disease.
    Solopchuk O; Sebti M; Bouvy C; Benoit CE; Warlop T; Jeanjean A; Zénon A
    Sci Rep; 2018 Aug; 8(1):12381. PubMed ID: 30120287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Will the mystery of Parkinson's disease be resolved?].
    Lyytinen J; Kaakkola S
    Duodecim; 2005; 121(3):275-84. PubMed ID: 15787285
    [No Abstract]   [Full Text] [Related]  

  • 15. The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress.
    Friedman A; Galazka-Friedman J
    Adv Neurol; 2001; 86():137-42. PubMed ID: 11553971
    [No Abstract]   [Full Text] [Related]  

  • 16. Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus.
    Grimbergen YA; Langston JW; Roos RA; Bloem BR
    Expert Rev Neurother; 2009 Feb; 9(2):279-90. PubMed ID: 19210201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and infection in Parkinson's disease.
    Arai H; Furuya T; Mizuno Y; Mochizuki H
    Histol Histopathol; 2006 Jun; 21(6):673-8. PubMed ID: 16528677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.